WHO ICTRP trial

The comparison of Ondansetron and Metoclopramide effect on postoperative nausea…

IRCT201601232954N8 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT201601232954N8
Public title The comparison of Ondansetron and Metoclopramide effect on postoperative nausea and vomiting
Scientific title Clinical trial of comparison of Ondansetron and Metoclopramide effect on postoperative nausea and vomiting in patients with appendisitis and cholecystitis
Primary sponsor Azad Islamic University, Shahroud Branch
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions Condition 1: Appendicitis. Condition 2: Cholecystitis. Condition 3: Nausea and vomiting. Acute appendicitis Cholecystitis Nausea and vomiting;Acute appendicitis;Cholecystitis;Nausea and vomiting
Interventions Intervention 1: Intervention: These patients receive 1 milligram per kg Ondansetron(made in Shahredaru Pharmaceutical Company in Islamic Republic Of Iran) single dose;intravenously. Intervention 2: These patients receive 15 milligram…
Registration date Oct 21, 2017
Target size 90
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations